Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cytosine drives evolution of SARS‐CoV‐2

15 Apr 2020

Abstract excerpt

In this article, we show, in the specific case of SARS-CoV-2, that the role of cytosine-based metabolites used as cell growth coordinators is central to understanding both innate antiviral immunity and the evolution of the virus. An outbreak of atypical pneumonia, first noticed in Wuhan, Hubei province, China (Huang et al., 2020), developed into the COVID-19 pandemic (Jee, 2020) that displayed alarming...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to SARS-CoV-2 and COVID-19 Research
Share to Viral Infections and Immunology Research
Share to Virus-based gene therapy research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32291894
DOI: 10.1111/1462-2920.15025

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cytosine drives evolution of SARS‐CoV‐2PMID 32291894Read ↗

Genome-Scale Metabolic Model of Infection with SARS-CoV-2 Mutants Confirms Guanylate Kinase as Robust Potential Antiviral TargetSemantic proximity Read ↗

Genome-Scale Metabolic Model of Infection with SARS-CoV-2 Mutants Confirms Guanylate Kinase as Robust Potential Antiviral Target.Semantic proximity Read ↗

Whole-body metabolic modelling predicts isoleucine dependency of SARS-CoV-2 replicationSemantic proximity Read ↗

Whole-body metabolic modelling predicts isoleucine dependency of SARS-CoV-2 replicationSemantic proximity Read ↗

SARS-CoV-2 hijacks folate and one-carbon metabolism for viral replicationSemantic proximity Read ↗

Inhibiting the reproduction of COVID-19-causing SARS-CoV-2 through perturbations in human cell metabolic networkSemantic proximity Read ↗

Repurposing Therapeutics to Identify Novel Inhibitors Targeting 2'-O-Ribose Methyltransferase Nsp16 of SARS-CoV-2Semantic proximity Read ↗

Vulnerabilities of the SARS-CoV-2 Virus to Proteotoxicity—Opportunity for Repurposed Chemotherapy of COVID-19 InfectionSemantic proximity Read ↗

Human cell-dependent, directional, time-dependent changes in the mono- and oligonucleotide compositions of SARS-CoV-2 genomesSemantic proximity Read ↗

Structural and dynamical analysis of integrated human/SARS-CoV-2 metabolic models present novel treatment strategies against COVID-19Semantic proximity Read ↗

Genome-scale metabolic modeling reveals SARS-CoV-2-induced metabolic changes and antiviral targetsSemantic proximity Read ↗

Genome‐scale metabolic modeling reveals SARS‐CoV‐2‐induced metabolic changes and antiviral targetsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.